Author

Christopher Veeck

Philipps University of MarburgORCID 0009-0005-3221-8447Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Anke WerneriD· 2 shared Stephan BeckeriD· 2 shared Gert BangeiD· 1 shared Lars‐Oliver EsseniD· 1 shared Laura WereliD· 1 shared Lennart LaubeiD· 1 shared Martin SchauflingeriD· 1 shared Wibke E. DiederichiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Anke WernerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintMay 30, 2026

Amino acid Mutations at the Interface of Sudan Virus VP40 alter transport and budding

Anke Werner, Wieland Steinchen, Christopher Veeck…·Stephan Becker

This study investigates how mutations at the oligomerization interface of Sudan virus VP40 affect its structural properties and functional roles in viral RNA synthesis and budding.

DOI 10.64898/2026.05.29.728849

experimental assaycell type annotation

𝕏 PostBluesky

MicrobiologybioRxivPreprintMay 3, 2025

Discovery of an Antiviral PROTAC Targeting the SARS-CoV-2 Main Protease Using an Allosteric Warhead

Christopher Veeck, Lennart Laube, Anke Werner…·Stephan Becker

This study develops an antiviral PROTAC targeting SARS-CoV-2 MPro using an allosteric warhead, showing LLP019 can degrade MPro and inhibit viral variants in infected cells.

2 citations

humanexperimental assay

𝕏 PostBluesky